Short Bowel Syndrome Market Growth, Trends & Demand by 2034
Short Bowel Syndrome Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug class (Glucagon-like Peptide, H2 Blockers, Proton Pump Inhibitors, Others); Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) , and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00011653
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Short Bowel Syndrome Market is growing at a CAGR of 5.15% from 2026 to 2034
The major factors driving the Short Bowel Syndrome Market are Rising Prevalence of Short Bowel Syndrome, Growing Number of Surgical Interventions, and Increased Awareness and Early Diagnosis of SBS.
Future trends in the Short Bowel Syndrome Market are the Growth of Home-Based Nutritional Support, Personalized Medicine and Targeted Therapies, and Integration of Artificial Intelligence (AI) in SBS Management.
Some of the players operating in the market are Takeda Pharmaceutical Company Limited, Zealand Pharma A/S, VectivBio AG, 9 Meters Biopharma, Inc, Hanmi Pharm.Co.,Ltd, GlaxoSmithKline, Plc, Cadila, Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Troikaa, AJANTA PHARMA.
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3-5 company profiles and a country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Short Bowel Syndrome Market - By Drug class
1.3.2 Short Bowel Syndrome Market - By Distribution channel
1.3.3 Short Bowel Syndrome Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SHORT BOWEL SYNDROME MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. SHORT BOWEL SYNDROME MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SHORT BOWEL SYNDROME MARKET - GLOBAL MARKET ANALYSIS
6.1. SHORT BOWEL SYNDROME - GLOBAL MARKET OVERVIEW
6.2. SHORT BOWEL SYNDROME - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SHORT BOWEL SYNDROME MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. GLUCAGON-LIKE PEPTIDE
7.3.1. Overview
7.3.2. Glucagon-like Peptide Market Forecast and Analysis
7.4. H2 BLOCKERS
7.4.1. Overview
7.4.2. H2 Blockers Market Forecast and Analysis
7.5. PROTON PUMP INHIBITORS
7.5.1. Overview
7.5.2. Proton Pump Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. SHORT BOWEL SYNDROME MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE SALES
8.5.1. Overview
8.5.2. Online Sales Market Forecast and Analysis
9. SHORT BOWEL SYNDROME MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Short Bowel Syndrome Market Overview
9.1.2 North America Short Bowel Syndrome Market Forecasts and Analysis
9.1.3 North America Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.1.4 North America Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.1.5 North America Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.1.5.1 United States Short Bowel Syndrome Market
9.1.5.1.1 United States Short Bowel Syndrome Market by Drug class
9.1.5.1.2 United States Short Bowel Syndrome Market by Distribution channel
9.1.5.2 Canada Short Bowel Syndrome Market
9.1.5.2.1 Canada Short Bowel Syndrome Market by Drug class
9.1.5.2.2 Canada Short Bowel Syndrome Market by Distribution channel
9.1.5.3 Mexico Short Bowel Syndrome Market
9.1.5.3.1 Mexico Short Bowel Syndrome Market by Drug class
9.1.5.3.2 Mexico Short Bowel Syndrome Market by Distribution channel
9.2. EUROPE
9.2.1 Europe Short Bowel Syndrome Market Overview
9.2.2 Europe Short Bowel Syndrome Market Forecasts and Analysis
9.2.3 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.2.4 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.2.5 Europe Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Short Bowel Syndrome Market
9.2.5.1.1 Germany Short Bowel Syndrome Market by Drug class
9.2.5.1.2 Germany Short Bowel Syndrome Market by Distribution channel
9.2.5.2 France Short Bowel Syndrome Market
9.2.5.2.1 France Short Bowel Syndrome Market by Drug class
9.2.5.2.2 France Short Bowel Syndrome Market by Distribution channel
9.2.5.3 Italy Short Bowel Syndrome Market
9.2.5.3.1 Italy Short Bowel Syndrome Market by Drug class
9.2.5.3.2 Italy Short Bowel Syndrome Market by Distribution channel
9.2.5.4 Spain Short Bowel Syndrome Market
9.2.5.4.1 Spain Short Bowel Syndrome Market by Drug class
9.2.5.4.2 Spain Short Bowel Syndrome Market by Distribution channel
9.2.5.5 United Kingdom Short Bowel Syndrome Market
9.2.5.5.1 United Kingdom Short Bowel Syndrome Market by Drug class
9.2.5.5.2 United Kingdom Short Bowel Syndrome Market by Distribution channel
9.2.5.6 Rest of Europe Short Bowel Syndrome Market
9.2.5.6.1 Rest of Europe Short Bowel Syndrome Market by Drug class
9.2.5.6.2 Rest of Europe Short Bowel Syndrome Market by Distribution channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Short Bowel Syndrome Market Overview
9.3.2 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis
9.3.3 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.3.4 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.3.5 Asia-Pacific Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Short Bowel Syndrome Market
9.3.5.1.1 Australia Short Bowel Syndrome Market by Drug class
9.3.5.1.2 Australia Short Bowel Syndrome Market by Distribution channel
9.3.5.2 China Short Bowel Syndrome Market
9.3.5.2.1 China Short Bowel Syndrome Market by Drug class
9.3.5.2.2 China Short Bowel Syndrome Market by Distribution channel
9.3.5.3 India Short Bowel Syndrome Market
9.3.5.3.1 India Short Bowel Syndrome Market by Drug class
9.3.5.3.2 India Short Bowel Syndrome Market by Distribution channel
9.3.5.4 Japan Short Bowel Syndrome Market
9.3.5.4.1 Japan Short Bowel Syndrome Market by Drug class
9.3.5.4.2 Japan Short Bowel Syndrome Market by Distribution channel
9.3.5.5 South Korea Short Bowel Syndrome Market
9.3.5.5.1 South Korea Short Bowel Syndrome Market by Drug class
9.3.5.5.2 South Korea Short Bowel Syndrome Market by Distribution channel
9.3.5.6 Rest of Asia-Pacific Short Bowel Syndrome Market
9.3.5.6.1 Rest of Asia-Pacific Short Bowel Syndrome Market by Drug class
9.3.5.6.2 Rest of Asia-Pacific Short Bowel Syndrome Market by Distribution channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Short Bowel Syndrome Market Overview
9.4.2 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis
9.4.3 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.4.4 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.4.5 Middle East and Africa Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Short Bowel Syndrome Market
9.4.5.1.1 South Africa Short Bowel Syndrome Market by Drug class
9.4.5.1.2 South Africa Short Bowel Syndrome Market by Distribution channel
9.4.5.2 Saudi Arabia Short Bowel Syndrome Market
9.4.5.2.1 Saudi Arabia Short Bowel Syndrome Market by Drug class
9.4.5.2.2 Saudi Arabia Short Bowel Syndrome Market by Distribution channel
9.4.5.3 U.A.E Short Bowel Syndrome Market
9.4.5.3.1 U.A.E Short Bowel Syndrome Market by Drug class
9.4.5.3.2 U.A.E Short Bowel Syndrome Market by Distribution channel
9.4.5.4 Rest of Middle East and Africa Short Bowel Syndrome Market
9.4.5.4.1 Rest of Middle East and Africa Short Bowel Syndrome Market by Drug class
9.4.5.4.2 Rest of Middle East and Africa Short Bowel Syndrome Market by Distribution channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Short Bowel Syndrome Market Overview
9.5.2 South and Central America Short Bowel Syndrome Market Forecasts and Analysis
9.5.3 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Drug class
9.5.4 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Distribution channel
9.5.5 South and Central America Short Bowel Syndrome Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Short Bowel Syndrome Market
9.5.5.1.1 Brazil Short Bowel Syndrome Market by Drug class
9.5.5.1.2 Brazil Short Bowel Syndrome Market by Distribution channel
9.5.5.2 Argentina Short Bowel Syndrome Market
9.5.5.2.1 Argentina Short Bowel Syndrome Market by Drug class
9.5.5.2.2 Argentina Short Bowel Syndrome Market by Distribution channel
9.5.5.3 Rest of South and Central America Short Bowel Syndrome Market
9.5.5.3.1 Rest of South and Central America Short Bowel Syndrome Market by Drug class
9.5.5.3.2 Rest of South and Central America Short Bowel Syndrome Market by Distribution channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SHORT BOWEL SYNDROME MARKET, KEY COMPANY PROFILES
11.1. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ZEALAND PHARMA A/S
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. VECTIVBIO AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. 9 METERS BIOPHARMA, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HANMI PHARM.CO.,LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLAXOSMITHKLINE, PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CADILA PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICAL INDUSTRIES LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TROIKAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. AJANTA PHARMA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For